Medications

Epinephrine personal autoinjectors cost-effective at $24

(HealthDay)—In a simulation of children with peanut allergy, epinephrine personal autoinjectors are cost-effective at $24, according to a study published online Nov. 16 in JAMA Network Open.

Medications

FDA extends EpiPen expiration dates to tackle shortage

(HealthDay)—The expiration dates of certain batches of EpiPens have been extended by the U.S. Food and Drug Administration in an effort to reduce shortages of the life-saving devices.

Medications

US approves first generic competitor to Mylan's EpiPen

US regulators Thursday approved the first generic alternative for the EpiPen, a life-saving emergency allergy medicine, two years after soaring prices for the original version owned by Mylan stoked controversy.

Cardiology

Epinephrine ups survival in out-of-hospital cardiac arrest

(HealthDay)—Epinephrine use results in improved 30-day survival versus placebo in patients with out-of-hospital cardiac arrest, according to a study published online July 18 in the New England Journal of Medicine.

Cardiology

Plasma catecholamines predict post-op A-fib after cardiac Sx

(HealthDay)—Assessment of plasma catecholamines on the morning of surgery can predict the likelihood of postoperative atrial fibrillation (POAF) for patients undergoing elective cardiac surgery, according to a study published ...

page 2 from 5